ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 677921 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 677921; 2) Community: the network communities that were significantly associated with the response to NSC 677921; 3) Molecule: the relationships between components within communities and NSC 677921; 4) MDR: the compounds that were significantly associated with the NSC 677921.

NSC Compound Enrichment Correlation
NSC 85701 Quinolinium, 6-ethoxy-2-[2-(8-hydroxy-5-quinolyl)vinyl]-1-methyl- iodide 0.0342636096654276 0.22956344
NSC 681279 5-Phenyl-4-oxo-oxadiazolo(5,4-c)quinolin-3-N-oxide (furoxan) 0.0385613993886 0.25142491
NSC 685981 1,4-Butanediamine, N,N'-bis[(2-naphthalenyl)methyl- N,N'-bis[3-[(trifluoroacetyl)amino]propyl]- 0.0385613993886 0.37529001
NSC 733755 Null 0.0385613993886 0.2593583
NSC 762557 Null 0.0385613993886 -0.14861272
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.0385613993886001 0.1089298
NSC 23925 Null 0.0385613993886001 0.32101174
NSC 267713 Digitoxigenin glycoside 0.0385613993886001 -0.28038699
NSC 303861 L-Cysteine analog 0.0385613993886001 0.23644307
NSC 321240 Null 0.0385613993886001 0.0010060359
Total:45  Current:27    [First] [Prev] [Next] [Last]